List of Biomarin Pharmaceutical patents

Patents where

Current Assignee

Name

Biomarin Pharmaceutical

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8178670 Method of synthesizing tetrahydrobiopterin	Patent 8178670 was granted and assigned to Biomarin Pharmaceutical (company) on May, 2012 by the United States Patent and Trademark Office.		Biomarin Pharmaceutical	United States Patent and Trademark Office	8178670	May 15, 2012
‌ US Patent 7264799 Use of heparinases to decrease inflammatory response	Patent 7264799 was granted and assigned to Biomarin Pharmaceutical (company) on September, 2007 by the United States Patent and Trademark Office.		Biomarin Pharmaceutical	United States Patent and Trademark Office	7264799	September 4, 2007
‌ US Patent 6979563 Attenuation of tumor growth, metastasis and angiogenesis	Patent 6979563 was granted and assigned to Biomarin Pharmaceutical on December, 2005 by the United States Patent and Trademark Office.		Biomarin Pharmaceutical	United States Patent and Trademark Office	6979563	December 27, 2005
‌ US Patent 10221408 Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof	Patent 10221408 was granted and assigned to Biomarin Pharmaceutical on March, 2019 by the United States Patent and Trademark Office.	Biomarin Pharmaceutical	Biomarin Pharmaceutical	United States Patent and Trademark Office	10221408	March 5, 2019
‌ US Patent 8377884 Variants of C-type natriuretic peptides	Patent 8377884 was granted and assigned to Biomarin Pharmaceutical on February, 2013 by the United States Patent and Trademark Office.		Biomarin Pharmaceutical	United States Patent and Trademark Office	8377884	February 19, 2013
‌ US Patent 10301369 Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins	Patent 10301369 was granted and assigned to Biomarin Pharmaceutical (company) on May, 2019 by the United States Patent and Trademark Office.	Biomarin Pharmaceutical	Biomarin Pharmaceutical	United States Patent and Trademark Office	10301369	May 28, 2019
‌ US Patent 9834588 Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof	Patent 9834588 was granted and assigned to Biomarin Pharmaceutical (company) on December, 2017 by the United States Patent and Trademark Office.	Biomarin Pharmaceutical	Biomarin Pharmaceutical	United States Patent and Trademark Office	9834588	December 5, 2017
‌ US Patent 9376480 Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof	Patent 9376480 was granted and assigned to Biomarin Pharmaceutical (company) on June, 2016 by the United States Patent and Trademark Office.	Biomarin Pharmaceutical	Biomarin Pharmaceutical	United States Patent and Trademark Office	9376480	June 28, 2016
‌ US Patent 11254725 Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof	Patent 11254725 was granted and assigned to Biomarin Pharmaceutical (company) on February, 2022 by the United States Patent and Trademark Office.	Biomarin Pharmaceutical	Biomarin Pharmaceutical	United States Patent and Trademark Office	11254725	February 22, 2022
‌ US Patent 9834587 Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof	Patent 9834587 was granted and assigned to Biomarin Pharmaceutical (company) on December, 2017 by the United States Patent and Trademark Office.	Biomarin Pharmaceutical	Biomarin Pharmaceutical	United States Patent and Trademark Office	9834587	December 5, 2017
‌ US Patent 8735392 Crystalline (8	Patent 8735392 was granted and assigned to Biomarin Pharmaceutical (company) on May, 2014 by the United States Patent and Trademark Office.		Biomarin Pharmaceutical	United States Patent and Trademark Office	8735392	May 27, 2014
‌ US Patent 9771408 Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof	Patent 9771408 was granted and assigned to Biomarin Pharmaceutical (company) on September, 2017 by the United States Patent and Trademark Office.	Biomarin Pharmaceutical	Biomarin Pharmaceutical	United States Patent and Trademark Office	9771408	September 26, 2017
‌ US Patent 6866844 Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme	Patent 6866844 was granted and assigned to Biomarin Pharmaceutical (company) on March, 2005 by the United States Patent and Trademark Office.		Biomarin Pharmaceutical	United States Patent and Trademark Office	6866844	March 15, 2005
‌ US Patent 9044473 Delivery of therapeutic compounds to the brain and other tissues	Patent 9044473 was granted and assigned to Biomarin Pharmaceutical (company) on June, 2015 by the United States Patent and Trademark Office.		Biomarin Pharmaceutical	United States Patent and Trademark Office	9044473	June 2, 2015
‌ US Patent 7442372 Delivery of therapeutic compounds to the brain and other tissues	Patent 7442372 was granted and assigned to Biomarin Pharmaceutical on October, 2008 by the United States Patent and Trademark Office.		Biomarin Pharmaceutical	United States Patent and Trademark Office	7442372	October 28, 2008
‌ US Patent 7560263 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof	Patent 7560263 was granted and assigned to Biomarin Pharmaceutical on July, 2009 by the United States Patent and Trademark Office.		Biomarin Pharmaceutical	United States Patent and Trademark Office	7560263	July 14, 2009
‌ US Patent 9089566 Delivery of therapeutic compounds to the brain and other tissues	Patent 9089566 was granted and assigned to Biomarin Pharmaceutical on July, 2015 by the United States Patent and Trademark Office.		Biomarin Pharmaceutical	United States Patent and Trademark Office	9089566	July 28, 2015
‌ US Patent 11040088 Delivery of therapeutic compounds to the brain and other tissues	Patent 11040088 was granted and assigned to Biomarin Pharmaceutical (company) on June, 2021 by the United States Patent and Trademark Office.	Biomarin Pharmaceutical	Biomarin Pharmaceutical	United States Patent and Trademark Office	11040088	June 22, 2021
‌ US Patent 9572870 Delivery of therapeutic compounds to the brain and other tissues	Patent 9572870 was granted and assigned to Biomarin Pharmaceutical on February, 2017 by the United States Patent and Trademark Office.	Biomarin Pharmaceutical	Biomarin Pharmaceutical	United States Patent and Trademark Office	9572870	February 21, 2017
‌ US Patent 7534595 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof	Patent 7534595 was granted and assigned to Biomarin Pharmaceutical on May, 2009 by the United States Patent and Trademark Office.		Biomarin Pharmaceutical	United States Patent and Trademark Office	7534595	May 19, 2009
‌ US Patent 7537923 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof	Patent 7537923 was granted and assigned to Biomarin Pharmaceutical on May, 2009 by the United States Patent and Trademark Office.		Biomarin Pharmaceutical	United States Patent and Trademark Office	7537923	May 26, 2009
‌ US Patent 9557340 Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase	Patent 9557340 was granted and assigned to Biomarin Pharmaceutical on January, 2017 by the United States Patent and Trademark Office.	Biomarin Pharmaceutical	Biomarin Pharmaceutical	United States Patent and Trademark Office	9557340	January 31, 2017
‌ US Patent 9469683 Lysosomal targeting peptides and uses thereof	Patent 9469683 was granted and assigned to Biomarin Pharmaceutical on October, 2016 by the United States Patent and Trademark Office.	Biomarin Pharmaceutical	Biomarin Pharmaceutical	United States Patent and Trademark Office	9469683	October 18, 2016
‌ US Patent 7531341 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof	Patent 7531341 was granted and assigned to Biomarin Pharmaceutical on May, 2009 by the United States Patent and Trademark Office.		Biomarin Pharmaceutical	United States Patent and Trademark Office	7531341	May 12, 2009
‌ US Patent 7981864 Methods and compositions for targeting proteins across the blood brain barrier	Patent 7981864 was granted and assigned to Biomarin Pharmaceutical (company) on July, 2011 by the United States Patent and Trademark Office.		Biomarin Pharmaceutical	United States Patent and Trademark Office	7981864	July 19, 2011

...

Results per page:

120 results

0 selected

120 results

0 selected